OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the cellular interactome of non-alcoholic fatty liver disease
Sebastian Wallace, Frank Tacke, Robert F. Schwabe, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100524-100524
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 291

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 152

Immunology of human fibrosis
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 63

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 60

Metabolic reprogramming in liver fibrosis
Paul Horn, Frank Tacke
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1439-1455
Open Access | Times Cited: 59

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 48

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Paul Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 679-688
Open Access | Times Cited: 48

The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Joscha Vonderlin, Triantafyllos Chavakis, Michael H. Sieweke, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1311-1324
Open Access | Times Cited: 46

Hepatic danger signaling triggers TREM2 + macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
Linkang Zhou, Xiaoxue Qiu, Ziyi Meng, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Closed Access | Times Cited: 16

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Timothy J. Kendall, Maria Jiménez Ramos, Frances Turner, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2939-2953
Open Access | Times Cited: 33

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
Zhiwen Fan, Xinyue Sun, Xuelian Chen, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100805-100805
Open Access | Times Cited: 24

Angiocrine signaling in sinusoidal homeostasis and liver diseases
Jinhang Gao, Tian Lan, Enis Kostallari, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 543-561
Closed Access | Times Cited: 13

Organoid-guided precision hepatology for metabolic liver disease
Sho Osonoi, Takanori Takebe
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 805-821
Closed Access | Times Cited: 11

Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study
Fahim Ebrahimi, Tracey G. Simon, Hannes Hagström, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3346-3355.e19
Open Access | Times Cited: 19

Fibroblasts in liver cancer: functions and therapeutic translation
Silvia Affò, Aveline Filliol, Gregory J. Gores, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 748-759
Open Access | Times Cited: 17

Targeting nuclear receptors for NASH/MASH: From bench to bedside
Rohit A. Sinha
Liver Research (2024) Vol. 8, Iss. 1, pp. 34-45
Open Access | Times Cited: 7

Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context
Adrien Guillot, Frank Tacke
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 6

Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 620-648
Open Access | Times Cited: 6

Therapeutic modulation of the liver immune microenvironment
Herbert Tilg, Timon E. Adolph, Frank Tacke
Hepatology (2023)
Closed Access | Times Cited: 15

Notch1 siRNA and AMD3100 Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease
Chunli Zhu, Yiheng Cheng, Lei Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 486-486
Open Access

Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases
Chenjie Zhan, Chunxiu Peng, Hui Wei, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2778-2778
Open Access

Role of regulatory T cells in inflammatory liver diseases
Linjie Yang, Song Guo Zheng
Autoimmunity Reviews (2025), pp. 103806-103806
Closed Access

Page 1 - Next Page

Scroll to top